Ikarian Capital, LLC 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:57 pm Purchase | 2022-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital, LLC | 138,277 12.500% | 3,721 (+2.77%) | Filing |
| 2023-02-14 11:26 am Sale | 2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Ikarian Capital, LLC | 11,638 0.300% | -63,845 (-84.58%) | Filing |
| 2022-02-14 4:43 pm Sale | 2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Ikarian Capital, LLC | 75,483 8.100% | -12,017 (-13.73%) | Filing |
| 2022-02-14 4:37 pm Sale | 2021-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital, LLC | 134,556 13.800% | -1,287 (-0.95%) | Filing |
| 2022-02-14 4:35 pm Sale | 2021-12-31 | 13G | scPharmaceuticals Inc. SCPH | Ikarian Capital, LLC | 901,362 3.300% | -564,785 (-38.52%) | Filing |
| 2022-02-14 4:34 pm Unchanged | 2021-12-31 | 13G | Science 37 Holdings, Inc. SNCE | Ikarian Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-04-08 09:02 am Purchase | 2021-03-23 | 13G | X4 Pharmaceuticals, Inc. XFOR | Ikarian Capital, LLC | 87,500 11.100% | 59,952 (+217.63%) | Filing |
| 2021-02-16 08:33 am Purchase | 2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital, LLC | 135,842 17.800% | 27,715 (+25.63%) | Filing |
| 2021-02-12 4:35 pm Purchase | 2020-12-31 | 13G | scPharmaceuticals Inc. SCPH | Ikarian Capital, LLC | 1,466,147 5.400% | 392,500 (+36.56%) | Filing |
| 2021-02-12 4:32 pm Sale | 2020-12-31 | 13G | Strongbridge Biopharma plc SBBP | Ikarian Capital, LLC | 2,440,028 3.600% | -802,759 (-24.76%) | Filing |
| 2021-02-12 4:31 pm Purchase | 2020-12-31 | 13G | KINETA INC KANT | Ikarian Capital, LLC | 132,514 1.300% | 132,514 (New Position) | Filing |
| 2021-02-12 4:31 pm Sale | 2020-12-31 | 13G | Verastem, Inc. VSTM | Ikarian Capital, LLC | 187,883 1.300% | -233,107 (-55.37%) | Filing |
| 2020-12-30 5:26 pm Purchase | 2020-12-29 | 13G | X4 Pharmaceuticals, Inc. XFOR | Ikarian Capital, LLC | 27,547 5.100% | 27,547 (New Position) | Filing |